Under construction – not a live service
Sign in
Taking people in GermanyNo phase

Fasting and exercise effects in people with metabolic syndrome

Tests fasting, with or without interval training, in adults with obesity and metabolic syndrome.

Plain-language title generated from the registry record
Registry title: Effects of Intermittent Fasting and Exercise on Inflammation, Metabolism, and the Microbiome in Metabolic Syndrome

Key facts

Where
Erlangen, GermanySee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 80 years old?

Source: NCT06885255, who can take part

Where in Germany

  • Hector-Center for Nutrition, Exercise and Sports, University Hospital ErlangenErlangen, GermanyTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
University of Erlangen-Nürnberg Medical School
Trial code
NCT06885255
Record updated
20 March 2025
Original description
The goal of this intervention trial is to assess the effects of intermittent fasting, both alone and in combination with high-intensity interval training, on patients with obesity and metabolic syndrome. The main question it aims to answer is:Read full original descriptionShow less

Effects of Intermittent Fasting and Its Combination with High-Intensity Interval Training on Inflammatory and Metabolic Markers, As Well As the Microbiome in Patients with Metabolic Syndrome: a Randomized Controlled Pilot Study

The goal of this intervention trial is to assess the effects of intermittent fasting, both alone and in combination with high-intensity interval training, on patients with obesity and metabolic syndrome. The main question it aims to answer is:

Does intermittent fasting, with or without high-intensity interval training, reduce chronic inflammation in patients with obesity and metabolic syndrome?

Participants will follow an intermittent fasting regime for 3 months, with one intervention group additionally participating in high-intensity interval training twice a week. In addition, there are two control groups: one consisting of participants with metabolic syndrome and one consisting of generally healthy individuals. The study includes a 3-month intervention phase followed by a 3-month follow-up phase. During the 6-month study period, all participants will attend 6 in-house study visits and 2 phone visits, during which they will undergo assessments and receive nutritional counseling.

Inclusion: Written consent to participate in the study; Persons aged 18 years and older; Diagnosis of Metabolic Syndrome (MetS) with elevated hsCRP.

Exclusion: Use of medication or supplements that significantly affect study outcomes (e.g., anti-inflammatory medications, antibiotics within the last 6 weeks); Cardiovascular diseases or orthopedic restrictions that prevent exercise; Individuals with mental illnesses that may impair their ability to understand or participate in the study; Pregnant or nursing individuals; Body weight greater than 200 kg (maximum capacity of training equipment).

ClinicalTrials.gov NCT06885255